Perrigo Company plc - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Perrigo Company plc on June 19, 2020. The filing reports a corporate governance event regarding the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the appointment of Katherine C. Doyle as a director of the Company and a member of its Audit Committee, effective July 29, 2020.
Management Commentary and Outlook
Murray S. Kessler, President and CEO, stated that Ms. Doyle's executive leadership experience, consumer products background, and expertise in e-commerce and retail will add significant value to Perrigo. There are no arrangements or understandings between Ms. Doyle and any other person regarding her selection. Her compensation will align with that of other non-employee directors as described in the Company's proxy statement filed on March 27, 2020.
Key Facts for Investor Verification
- New Director: Katherine C. Doyle appointed to the Board and Audit Committee.
- Effective Date: July 29, 2020.
- Relevant Experience: Former CEO of Swanson Health Products (2016-2019); former executive at Abbott Laboratories; 20+ years at McKinsey & Company.
- Current Board Roles: Director of AholdDelhaize (Chair of Sustainability and Innovation Committee; Audit Committee member).
- Compensation: Subject to standard non-employee director compensation outlined in the March 27, 2020 proxy statement.